OVERVIEW

Expert Updates on Diagnosing and Managing Eosinophilic Granulomatosis with Polyangiitis
is organized by Rockpointe Corporation.

Release date: February 3, 2020
Expiration date: February 3, 2021

Accreditation:
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Abim Moc Designation Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Overview:
Because EGPA is a rare condition, it is not always considered when evaluating patients with vasculitis. The lack of established EGPA diagnostic criteria has also contributed to diagnostic delays. Even after proper diagnosis, there is little guidance on how to individualize EGPA treatment plans as part of a multidisciplinary team. As such, clinicians may not yet be aware of the latest advances in EGPA care, including the first agent approved to treat EGPA.

Educational Objectives:
This program is designed to address the following NAM competencies: provide patient-centered care and employ evidence-based practice.
At the conclusion of this activity, participants should be able to:
• Identify the signs, symptoms, and laboratory results that indicate a diagnosis of EGPA
• Create a personalized treatment regimen for patients with EGPA using clinical characteristics and laboratory studies
• Recognize signs and symptoms of disease relapse in patients being treated for EGPA
• Reinforce the need for a multidisciplinary team to address varied disease symptoms

Additional details will be posted as soon as information is available.